The German Dermatological Society (DDG) has updated its acne guideline, Pharmazeutische Zeitung reports on November 12, 2026. According to the report, topical retinoids are considered the first choice for mild to moderate comedonal acne.
Comedonal Acne: How the Report Positions Retinoids

According to the report, the guideline favors adapalene over tretinoin and isotretinoin among topical preparations. It cites a more favorable tolerability and safety profile as the reason. This comparison does not concern oral retinoids.
The recommendation applies to comedonal acne, not to every form of acne across the board.
The article mentions trifarotene as another alternative. However, in the absence of comparative studies, the guideline group has not yet made an evidence-based assessment of this active ingredient. Its inclusion therefore does not establish superiority over the other active ingredients mentioned.
For people who use cosmetic skin care services for blackheads, the report provides a medical point of reference: it describes medications for treating acne, not cosmetic services.
Effects, Irritation, and Pregnancy: Important Limitations

According to Pharmazeutische Zeitung, topical retinoids, meaning those applied to the skin, can be expected to take effect after four to eight weeks. The skin's condition may initially worsen.
Possible signs of irritation include itching, burning, and stinging. According to Schaller, the expert quoted in the article, irritation generally subsides after four weeks. This describes tolerability, not the onset of action.
Topical retinoids must not be used during pregnancy.
A medical assessment therefore considers more than potential improvements in the skin. The time until treatment takes effect, tolerability, and the limitations of the available evidence are equally relevant.
If you would like to discuss questions about cosmetic skin care services at the studio, you can schedule an appointment. Medical assessment of acne treatment remains separate from this.
Sources: Topical Treatments for Acne Comedonica | PZ – Pharmazeutische Zeitung
